Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC Beroterkib anhydrous | 2095719-92-7 | 99.9% | 584.04 g·mol⁻¹ | C29H31ClFN5O5 | 100MG
Supplier: Medchemexpress LLC HY126288100MG
ASTX029 (beroterkib) is a small-molecule, dual-mechanism inhibitor of extracellular signal-regulated kinases ERK1 and ERK2 developed as a clinical candidate. It potently inhibits ERK catalytic activity and suppresses ERK phosphorylation, showing low-nanomolar biochemical and cellular potency and intended for preclinical research into MAPK-driven cancers. Supplied for research use only.
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?